TCT 2009 schedule: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 28: Line 28:
===1:00 PM===
===1:00 PM===
''1:05 PM - 1:15 PM''
''1:05 PM - 1:15 PM''
*'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations (''Lecturer'')
*'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
*'''Room:''' 104
*'''Room:''' 104


''1:51 PM - 2:03 PM''
''1:51 PM - 2:03 PM''
*'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations (''Discussant'')
*'''Event:''' The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations  
*'''Room:''' 104
*'''Room:''' 104


Line 41: Line 41:
===10:00 AM===
===10:00 AM===
''10:00 AM - 12:00 PM''
''10:00 AM - 12:00 PM''
*'''Event:''' Oral Abstracts- AMI (''Moderator'')
*'''Event:''' Oral Abstracts- AMI  
*'''Room:''' 125
*'''Room:''' 125


Line 48: Line 48:
== Wednesday September 23, 2009==
== Wednesday September 23, 2009==


===12:00 PM===
===12:45 PM===
''12:45 PM - 12:50 PM''
''12:45 PM - 12:50 PM''
*'''Event:''' Open Issues I: Adjunct Pharmacology. Schedule (''Lecturer'')
*'''Event:''' Open Issues I: Adjunct Pharmacology. Schedule  
*'''Room:''' 130
*'''Room:''' 130


===1:00 PM===
===1:35 PM===
''1:35 PM - 1:45 PM''
''1:35 PM - 1:45 PM''
*'''Event:''' Open Issues I: Adjunct Pharmacology. Schedule (''Discussant'')
*'''Event:''' Open Issues I: Adjunct Pharmacology. Schedule  
*'''Room:''' 130
*'''Room:''' 130


===4:00 PM===
===4:00 PM===
''4:00 PM - 4:45 PM''
''4:00 PM - 4:45 PM''
*'''Event:''' Main Arena I. Plenary Session #7 Personalized Clinical Decision-Making Case Study: The Ischemia vs. Bleeding Controversy (''Panel Discussant'')
*'''Event:''' Main Arena I. Plenary Session #7 Personalized Clinical Decision-Making Case Study: The Ischemia vs. Bleeding Controversy  
*'''Room:''' Esplanade Ballroom
*'''Room:''' Esplanade Ballroom
''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''
''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''


== Thursday September 24, 2009==
== Thursday September 24, 2009==
===8:45 AM===
''8:46 AM - 11:11 AM''
*'''Event:''' Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 2: Current Choices in Antithrombin Therapy for ACS and PCI
*'''Room:''' 135
===11:45 PM===
''11:45 AM - 11:57 AM''
*'''Event:''' Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
*'''Room:''' 135
===12:09 PM===
''12:09 PM - 12:24 PM''
*'''Event:''' Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
*'''Room:''' 135
===5:02 PM===
''5:02 PM - 5:14 PM''
*'''Event:''' Balancing Safety and Efficacy of Antithrombotic Therapies for PCI and ACS. Antiplatelet Agents, Bleeding, and Ischemia
*'''Room:''' 135


''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''
''[[TCT 2009 schedule#Click on Date for Detailed Schedule|Return to top]]''

Revision as of 13:36, 7 August 2009

Here is the page we will use to coordinate the TV events at TCT 2009.



Click on Date for Detailed Schedule

Sunday September 20, 2009

Monday September 21, 2009

Tuesday September 22, 2009

Wednesday September 23, 2009

Thursday September 24, 2009

Friday September 25, 2009


Sunday September 20, 2009

Return to top

Monday September 21, 2009

1:00 PM

1:05 PM - 1:15 PM

  • Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
  • Room: 104

1:51 PM - 2:03 PM

  • Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
  • Room: 104

Return to top

Tuesday September 22, 2009

10:00 AM

10:00 AM - 12:00 PM

  • Event: Oral Abstracts- AMI
  • Room: 125

Return to top

Wednesday September 23, 2009

12:45 PM

12:45 PM - 12:50 PM

  • Event: Open Issues I: Adjunct Pharmacology. Schedule
  • Room: 130

1:35 PM

1:35 PM - 1:45 PM

  • Event: Open Issues I: Adjunct Pharmacology. Schedule
  • Room: 130

4:00 PM

4:00 PM - 4:45 PM

  • Event: Main Arena I. Plenary Session #7 Personalized Clinical Decision-Making Case Study: The Ischemia vs. Bleeding Controversy
  • Room: Esplanade Ballroom

Return to top

Thursday September 24, 2009

8:45 AM

8:46 AM - 11:11 AM

  • Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 2: Current Choices in Antithrombin Therapy for ACS and PCI
  • Room: 135

11:45 PM

11:45 AM - 11:57 AM

  • Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
  • Room: 135

12:09 PM

12:09 PM - 12:24 PM

  • Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
  • Room: 135

5:02 PM

5:02 PM - 5:14 PM

  • Event: Balancing Safety and Efficacy of Antithrombotic Therapies for PCI and ACS. Antiplatelet Agents, Bleeding, and Ischemia
  • Room: 135

Return to top

Friday September 25, 2009

Return to top